Luis Diaz's Bayern deal moves €100m transfer closer
The Colombian winger's contract was ticking down - set to expire in 2027 - and so Richard Hughes took the decision to let him go.
🔴
Shop the LFC Store
LFC x adidas
Shop the home range today!
LFC x adidas
Shop the goalkeeper range today
LFC x adidas
Shop the new adidas range today!
Arne Slot's squad is well covered in the left-wing area despite the loss of Diaz. Cody Gakpo performs best on the left side of attack and Rio Ngumoha looks set to receive significant minutes in that sector next season.
🔴 Shop the LFC 2025/26 adidas away range from 9am TODAY
Don't forget Florian Wirtz and Hugo Ekitike either. Those two former Bundesliga stars are multifaceted attackers - who Liverpool decision-makers see as potential solutions on the left side.
Mac Allister upset over Diaz sale
You can add the proceeds of Diaz's £65m sale to the Bavarians to the cash pile being readied for a SECOND bid for Alexander Isak too.
In short, this transfer has plenty of upsides - even if Liverpool must find 13 Premier League goals from someone else next season.
All is rosy in the garden? Not quite.
Because now a report comes in from Spain which suggests Alexis Mac Allister is dismayed at the sale of his fellow South American.
Mac Allister, 26, posted on social media earlier this week that he was in tears following Diaz's departure. And now Defensa Central claims that the Argentina World Cup winner is considering his future at the club.
Real Madrid want Mac Allister
'The Argentine is very upset with the sale of Luis Diaz, whom he considered his brother at Liverpool,' the report states.
Now it must be borne in mind that this outlet is very much biased towards Real Madrid. And if they spot an opportunity to send a transfer target towards the Bernabeu then they will take it.
It's been reported that Mac Allister is a favourite of Xabi Alonso - and he was just as admired by previous Madrid coaching incumbent Carlo Ancelotti.
Madrid are certainly sniffing around and are still in need of a proper successor Toni Kroos and Luka Modric.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
BP reveals plans for group-wide costs and business review as profits fall
BP bosses have unveiled plans to look for further cost cuts and conduct a 'thorough' review of its portfolio as it comes under pressure from shareholders. Chief executive Murray Auchincloss pledged the oil and gas group would do 'better for its investors' and said there was 'much more to do' under its current three-year plan. BP has been under pressure from shareholders to boost profits and cut costs, with activist investor Elliott Management recently taking a 5% stake in the group. The group saw half-year profits tumble by nearly a third as weaker oil prices weighed on earnings, although it posted a better-than-expected performance for the second quarter. It reported a 32% fall in underlying replacement cost profits – the group's preferred profit measure – to 3.73 billion US dollars (£2.81 billion) for the six months to June 30. Underlying profits fell 15% year-on-year to 2.35 billion dollars (£1.77 billion) between April and June, although this was a significant improvement from 1.38 billion dollars (£1.04 billion) in the first quarter and better than most analysts had forecast. BP's aims to ramp up its overhaul process follows talks with incoming chairman Albert Manifold who starts next month, Mr Auchincloss said. Mr Auchincloss said: 'He and I have been in discussions and have agreed that we will conduct a thorough review of our portfolio of businesses to ensure we are maximising shareholder value moving forward. 'We are also initiating a further cost review and, whilst we will not compromise on safety, we are doing this with a view to being best in class in our industry.' 'BP can and will do better for its investors,' he added. In another move to appease shareholders, the FTSE 100 firm also said it would buy back another 750 million dollars (£565 million) in shares and hike the quarterly dividend payout by 4%.
Yahoo
10 minutes ago
- Yahoo
SI-BONE Inc (SIBN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Positive ...
Worldwide Revenue: $48.6 million, growth of 21.7%. US Revenue: $46.4 million, growth of 22.8%. International Revenue: $2.2 million. Gross Profit: $38.8 million, increase of $7.2 million. Gross Margin: 79.8%, expanded by 80 basis points year-over-year. Operating Expenses: $45.8 million, increase of $4.2 million. Net Loss: $6.2 million or $0.14 per diluted share. Adjusted EBITDA: Positive $1 million, compared to a loss of $2.7 million in the prior year. Cash and Marketable Securities: $145.5 million, up from $144.4 million. Full Year Revenue Guidance: $195 million to $198 million, growth of approximately 17% to 18%. Full Year Gross Margin Guidance: 78.5% to 79%. Warning! GuruFocus has detected 3 Warning Signs with SIBN. Release Date: August 04, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points SI-BONE Inc (NASDAQ:SIBN) reported a worldwide revenue growth of approximately 22% for the second quarter of 2025, with US revenue growing by 23%. The company achieved cash flow break-even ahead of schedule, marking a significant financial milestone. SI-BONE Inc (NASDAQ:SIBN) experienced a 25% increase in US procedure volumes, indicating strong demand across its target markets. The launch of iFuse TORQ in Europe is expected to accelerate adoption and growth in international markets. The company delivered its third consecutive quarter of positive adjusted EBITDA, demonstrating consistent profitability. Negative Points International revenue growth was impacted by a later-than-expected regulatory clearance for iFuse TORQ in Europe. The average procedure ASP declined slightly, although it remained more stable than initially expected. There is an anticipated sequential revenue decline of approximately 4% in Q3 due to seasonality and certifications. Gross margins are expected to be dynamic over the next few years, with potential compression due to new product launches and associated costs. The company faces ongoing pricing pressure, with an assumed 2% ASP decline in the second half of the year. Q & A Highlights Q: Can you discuss the assumptions underlying the revenue growth guidance for the second half of 2025, given the strong growth in the first half? A: Laura Francis, CEO: We are pleased with the 23% US growth and the acceleration between Q1 and Q2. Our strategy is working, and we are growing towards profitability. We achieved cash flow breakeven earlier than expected. Anshul Maheshwari, CFO, added that while there are tailwinds like Granite adoption and TNT capacity, they are maintaining a prudent approach to guidance, expecting a sequential decline in Q3 due to seasonality, with a ramp in Q4. Q: How should we think about gross margin guidance, given the strong performance in the first half of 2025? A: Anshul Maheshwari, CFO: We started the year expecting 77% to 78% gross margins, but have outperformed. We are now guiding 78.5% to 79% for the year. We are embedding some ASP pressure and costs from new product launches, but there is potential for better-than-anticipated ASP and additional margin improvement initiatives. Q: Can you provide more color on the growth of interventional docs using your products and their impact? A: Laura Francis, CEO: Interventional docs have been a strong growth driver since we started working with them over a year ago. TORQ is the product of choice, but many also use our INTRA product where reimbursement is defined. Interventionalists are often in areas where surgeons are not performing these procedures, providing a nice balance. Q: What is the potential for Granite procedures to move to outpatient settings, and how does this impact your business? A: Laura Francis, CEO: CMS has proposed allowing higher-cost lumbar fusion procedures in outpatient settings, which could increase Granite's use in these settings. Granite's transitional pass-through code and $0 device offset could drive more procedures to outpatient settings, especially short construct degenerative spine procedures. Q: How are you prioritizing capital deployment given your cash flow breakeven achievement? A: Anshul Maheshwari, CFO: We expect revenue growth to outpace OpEx growth, with continued investments in R&D and sales force expansion. We aim for 10% of revenue in R&D, with sales and marketing growth aligned with revenue growth. We have the liquidity to invest in organic growth initiatives. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 minutes ago
- Yahoo
Ameresco Inc (AMRC) Q2 2025 Earnings Call Highlights: Record Backlog and Strong Financial ...
Revenue Growth: 8% increase in second-quarter revenue. Adjusted EBITDA Growth: 24% increase in adjusted EBITDA. Gross Margin: 15.5% for the quarter. Net Income: $12.9 million attributable to common shareholders. Earnings Per Share (EPS): $0.24 per share, with non-GAAP EPS of $0.27. Adjusted EBITDA Margin: Nearly 12%. Total Project Backlog: Increased 16% to a record $5.1 billion. Contracted Project Backlog: Up 46% to $2.4 billion. Total Revenue Visibility: Almost $10 billion. Cash and Debt: $82 million in cash and total corporate debt of $294 million. Debt to EBITDA Leverage Ratio: 3.4 times. Adjusted Cash Flows from Operations: Approximately $50 million. New Project Financing Proceeds: Approximately $170 million raised. Warning! GuruFocus has detected 8 Warning Signs with AMRC. Release Date: August 04, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Ameresco Inc (NYSE:AMRC) reported strong financial performance with an 8% increase in revenue and a 24% rise in adjusted EBITDA for the second quarter. The company has a diversified project backlog, which increased by 16% to a record $5.1 billion, providing strong revenue visibility. Ameresco Inc (NYSE:AMRC) is experiencing significant growth in Europe, which now accounts for approximately 20% of its total project backlog. The company is well-positioned to capitalize on the increasing demand for energy infrastructure solutions, driven by rising electricity prices and grid instability. Ameresco Inc (NYSE:AMRC) is investing in future technologies such as small modular reactors and expanding its European operations, indicating a forward-looking growth strategy. Negative Points The company faces challenges with equipment supply, particularly with long lead times for transformers and gas turbines. There is potential exposure related to the bankruptcy of battery supplier Powin, with a claim of approximately $27 million. The divestiture of the AEG business led to a decline in revenue from the 'other' line of business. The impact of the 'One Big Beautiful Bill' on Ameresco Inc (NYSE:AMRC) remains uncertain, with no significant near-term effects expected. The company is navigating potential disruptions in battery supply due to tariffs and foreign entity concerns, which could impact future projects. Q & A Highlights Q: Can you discuss Ameresco's cash generation and net leverage perspective for the year-end, considering project financing and large project completions? A: Joshua Baribeau, Senior Vice President & Chief Investment Officer, stated that while Ameresco does not provide specific leverage guidance, they feel comfortable with their current position. As EBITDA grows and project collections occur, they expect leverage to potentially decrease. However, they remain flexible to adjust if interesting projects arise that require additional working capital. Q: What factors are driving the increase in contracted backlog, and how do you view the margin profile of these projects? A: George Sakellaris, CEO, explained that the demand for infrastructure upgrades and energy solutions is driving the conversion from awarded to contracted backlog, which increased by 46% year-over-year. The margin profile is improving, with a slight uptick in project margins, especially in Europe, where initial lower-margin projects helped establish credibility. Q: How is Ameresco positioned in the data center infrastructure market, and what opportunities do you see there? A: Nicole Bulgarino, President of Federal Solutions and Utility Infrastructure, highlighted Ameresco's role in providing energy solutions for data centers, addressing power shortages, and supporting AI developments. They are working on several early-stage projects and see significant opportunities in this sector. Q: How are equipment supply issues, particularly for natural gas turbines and battery cells, impacting Ameresco's growth trajectory? A: George Sakellaris noted that while there are tight supplies for transformers and long timelines for gas turbines, Ameresco has managed to secure necessary equipment without significant project delays. They have better availability for gas engines and smaller transformers, which suit their distributed generation projects. Q: What is Ameresco's strategy for growth in Europe, and are there plans for acquisitions? A: George Sakellaris stated that Ameresco's strategy includes both organic growth and potential acquisitions. They have hired a seasoned executive to lead European expansion, focusing on high-growth markets like Greece, Italy, and Spain. They are also exploring battery storage opportunities in Europe. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
